rosiglitazone has been researched along with carbachol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bajwa, PJ; Lee, JW; Lytle, C; Straus, DS | 1 |
Adinolfi, B; Bardelli, C; Betti, L; Breschi, MC; Brunelleschi, S; Fabbrini, L; Fogli, S; Giannaccini, G; Lucacchini, A; Mariotti, V; Melissari, E; Pellegrini, S; Stefanelli, F | 1 |
3 other study(ies) available for rosiglitazone and carbachol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
Topics: Administration, Oral; Animals; Calcium; Carbachol; Chlorides; Cholera Toxin; Colforsin; Colon; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Disease Models, Animal; Electric Impedance; Female; Gastrointestinal Agents; HT29 Cells; Humans; Ileum; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Intestinal Secretions; Intestines; Jejunum; KCNQ1 Potassium Channel; Mice; Pioglitazone; PPAR gamma; Rosiglitazone; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Thiazolidinediones; Time Factors | 2009 |
Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthma; Carbachol; Cells, Cultured; Dexamethasone; Drug Tolerance; Guinea Pigs; Humans; In Vitro Techniques; Male; Muscle, Smooth; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Respiratory System; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Trachea | 2011 |